OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive assessment of neurocognitive and psychological functioning in adults with early-treated phenylketonuria
Hayley E. Clocksin, Emily E. Abbene, Shawn E. Christ
Journal of the International Neuropsychological Society (2022) Vol. 29, Iss. 7, pp. 641-650
Closed Access | Times Cited: 13

Showing 13 citing articles:

Cognition after a 4-week high phenylalanine intake in adults with phenylketonuria – a randomized controlled trial
Roman Trepp, Raphaela Muri, Stephanie Maissen‐Abgottspon, et al.
American Journal of Clinical Nutrition (2024) Vol. 119, Iss. 4, pp. 908-916
Open Access | Times Cited: 11

Two years of pegvaliase in Germany: Experiences and best practice recommendations
Johannes Krämer, Christoph Baerwald, Christian Heimbold, et al.
Molecular Genetics and Metabolism (2023) Vol. 139, Iss. 1, pp. 107564-107564
Open Access | Times Cited: 16

Phenylketonuria in adults: we know plenty, but there is much more to learn
Cary O. Harding, Georgianne L. Arnold, Susan A. Berry, et al.
American Journal of Clinical Nutrition (2025)
Closed Access

Neuropsychological assessment of adults with phenylketonuria using the NIH toolbox
Shawn E. Christ, Hayley E. Clocksin, Maia Zalik, et al.
Molecular Genetics and Metabolism (2023) Vol. 139, Iss. 1, pp. 107579-107579
Closed Access | Times Cited: 7

No Impairment in Bone Turnover or Executive Functions in Well-Treated Preschoolers with Phenylketonuria—A Pilot Study
Beatrice Hanusch, Michael Falkenstein, Stefan Volkenstein, et al.
Nutrients (2024) Vol. 16, Iss. 13, pp. 2072-2072
Open Access | Times Cited: 2

Metabolic control and clinical outcome in adolescents with phenylketonuria
Agnese De Giorgi, Francesca Nardecchia, Cristina Romani, et al.
Molecular Genetics and Metabolism (2023) Vol. 140, Iss. 3, pp. 107684-107684
Closed Access | Times Cited: 4

Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup
Susan E. Waisbren, Shawn E. Christ, Deborah A. Bilder, et al.
Molecular Genetics and Metabolism (2024) Vol. 143, Iss. 1-2, pp. 108555-108555
Closed Access | Times Cited: 1

Beyond neuropsychological tests: AI speech analysis in PKU
Susan E. Waisbren, Raquel Norel, Carla Agurto, et al.
Journal of Inherited Metabolic Disease (2024) Vol. 48, Iss. 1
Closed Access | Times Cited: 1

Expert Consensus on the Long-Term Effectiveness of Medical Nutrition Therapy and Its Impact on the Outcomes of Adults with Phenylketonuria
Júlio César Rocha, Kirsten Ahring, Heather Bausell, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 3940-3940
Open Access | Times Cited: 3

Sepiapterin: a potential new therapy for phenylketonuria
Cary O. Harding
The Lancet (2024) Vol. 404, Iss. 10460, pp. 1284-1286
Closed Access

Page 1

Scroll to top